DE3581578D1 - Antikoerper, herstellung und verwendung. - Google Patents

Antikoerper, herstellung und verwendung.

Info

Publication number
DE3581578D1
DE3581578D1 DE8585901495T DE3581578T DE3581578D1 DE 3581578 D1 DE3581578 D1 DE 3581578D1 DE 8585901495 T DE8585901495 T DE 8585901495T DE 3581578 T DE3581578 T DE 3581578T DE 3581578 D1 DE3581578 D1 DE 3581578D1
Authority
DE
Germany
Prior art keywords
antibodies
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585901495T
Other languages
English (en)
Inventor
Henry Self
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Patent Developments Ltd
Original Assignee
Cambridge Patent Developments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10558906&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3581578(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cambridge Patent Developments Ltd filed Critical Cambridge Patent Developments Ltd
Application granted granted Critical
Publication of DE3581578D1 publication Critical patent/DE3581578D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8585901495T 1984-03-30 1985-03-29 Antikoerper, herstellung und verwendung. Expired - Lifetime DE3581578D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848408193A GB8408193D0 (en) 1984-03-30 1984-03-30 Antibodies
PCT/GB1985/000120 WO1985004422A1 (en) 1984-03-30 1985-03-29 Antibodies, manufacture and use

Publications (1)

Publication Number Publication Date
DE3581578D1 true DE3581578D1 (de) 1991-03-07

Family

ID=10558906

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585901495T Expired - Lifetime DE3581578D1 (de) 1984-03-30 1985-03-29 Antikoerper, herstellung und verwendung.

Country Status (9)

Country Link
US (1) US4840895A (de)
EP (1) EP0177531B1 (de)
JP (1) JPH06102037B2 (de)
AU (1) AU584332B2 (de)
CA (1) CA1277262C (de)
DE (1) DE3581578D1 (de)
GB (1) GB8408193D0 (de)
WO (1) WO1985004422A1 (de)
ZA (1) ZA852438B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161165A (en) * 1984-06-12 1986-01-08 Cambridge Patent Dev Secondary antibodies
US4689400A (en) * 1985-06-27 1987-08-25 The United States Of America As Represented By The Secretary Of The Navy Enhancement of specific antibody production with anti-IgD antibodies
EP0247730A3 (de) * 1986-04-28 1989-04-12 Antibody Technology Limited Antikörper, ihre Herstellung sowie Verwendung und dieselben enthaltende Produkte
JPH0690206B2 (ja) * 1986-06-16 1994-11-14 日本赤十字社 抗原抗体複合物及びその使用方法
GB8616174D0 (en) * 1986-07-02 1986-08-06 Antibody Technology Ltd Monoclonal antibodies
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
IT1223136B (it) * 1987-11-17 1990-09-12 Ist Naz Stud Cura Dei Tumori Anticorpi monoclonali capaci di legarsi selettivamente alla doxorubicina ed analoghi e derivati
US5468651A (en) * 1987-11-28 1995-11-21 Cambridge Patent Developments Limited Method for determining haptens, use of method and components useful in method
JP2669703B2 (ja) * 1987-11-28 1997-10-29 ケンブリッジ パテント デヴェロプメンツ リミテッド 測定法、用途及び構成部品
GB8800419D0 (en) * 1988-01-08 1988-02-10 Amersham Int Plc Method for measuring free fraction of ligands in biological fluids
GB8827522D0 (en) * 1988-11-25 1988-12-29 Cambridge Patent Dev Small analyte assays
FR2652163B1 (fr) * 1989-09-20 1994-04-15 Bio Merieux Procede de detection d'une substance biologique a l'aide de ligands.
CA2082529A1 (en) * 1990-05-25 1991-11-26 Denis R. Stanworth Immunodiagnostic assay for rheumatoid arthritis
CA2072758A1 (en) * 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
JP3291525B2 (ja) * 1990-12-20 2002-06-10 株式会社ヤトロン ヒトプラスミン−α▲下２▼−プラスミンインヒビター複合体の免疫学的測定方法
AU3359493A (en) * 1992-01-17 1993-08-03 Selective Antibodies Limited Determination of haptens
DE9216110U1 (de) * 1992-11-26 1993-01-28 Biolab GmbH, 80995 München Progesteron-Schnelltest für Mensch und Haustiere
US5998222A (en) * 1993-11-29 1999-12-07 Utah State University Reconditioning antibiotic-adulterated milk products
JPH11153599A (ja) * 1997-11-21 1999-06-08 Dai Ichi Pure Chem Co Ltd 免疫学的測定方法
JP4228095B2 (ja) * 1999-12-17 2009-02-25 東ソー株式会社 免疫測定方法および免疫測定試薬
GB0707870D0 (en) 2007-04-23 2007-05-30 Selected Antibodies Ltd Assay Devices and Methods and Components for use Therein
DE102008049601A1 (de) 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
JP6156144B2 (ja) * 2011-09-21 2017-07-05 富士レビオ株式会社 親和性複合体に対する抗体
US11261257B2 (en) 2013-01-28 2022-03-01 Diasorin S.P.A. Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
US10983136B2 (en) 2013-01-28 2021-04-20 Diasorin S.P.A. Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
PL2759550T3 (pl) * 2013-01-28 2019-01-31 Diasorin S.P.A. Sposób i zestaw do wykrywania 1,25-dihydroksywitaminy D i powiązane przeciwciała
GB201310837D0 (en) 2013-06-18 2013-07-31 Dupont Teijin Films Us Ltd Polyester film -IV
US20210302417A1 (en) 2018-09-28 2021-09-30 Siemens Healthcare Diagnostics Inc. Complex stabilizing components and detection methods thereof
WO2021030136A1 (en) * 2019-08-09 2021-02-18 The Regents Of The University Of California ANTIBODY CHEMICALLY INDUCED DIMERIZERS (AbCID) AS MOLECULAR SWITCHES AND USES THEREOF
CN114746754A (zh) * 2019-11-20 2022-07-12 东曹株式会社 使用抗免疫复合物抗体的测定方法
WO2021182558A1 (ja) * 2020-03-12 2021-09-16 日立化成ダイアグノスティックス・システムズ株式会社 試料中の対象物質を免疫測定するための方法及びキット
JP2023060976A (ja) * 2021-10-19 2023-05-01 東ソー株式会社 テストステロン濃度の測定方法
CN116041527A (zh) * 2023-01-05 2023-05-02 深圳市新产业生物医学工程股份有限公司 一种特异性结合e2-e2抗体复合物的抗体及其应用
CN116284384B (zh) * 2023-04-13 2025-10-10 郑州伊美诺生物技术有限公司 孕酮重组单克隆抗体制备方法及应用
CN116333115B (zh) * 2023-05-12 2023-07-28 北京纳百生物科技有限公司 一种抗孕酮的单克隆抗体、试剂盒及应用
CN117871841B (zh) * 2023-12-07 2025-11-04 深圳市新产业生物医学工程股份有限公司 雌二醇样本处理剂及其在雌二醇检测中的应用和检测方法
CN117907589A (zh) * 2023-12-07 2024-04-19 深圳市新产业生物医学工程股份有限公司 夹心法检测样本中目标分子的方法
CN117871874A (zh) * 2023-12-07 2024-04-12 深圳市新产业生物医学工程股份有限公司 小分子物质免疫检测方法
CN117805363B (zh) * 2023-12-31 2025-10-17 深圳市新产业生物医学工程股份有限公司 消除血清血浆样本检测差异的小分子检测方法及试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364347D1 (en) * 1982-04-09 1986-08-07 Fujirebio Kk Anti immune complex antibody and preparation thereof
JPS5999258A (ja) * 1982-11-29 1984-06-07 Fujirebio Inc 抗免疫複合体抗体の製造方法
US4606855A (en) * 1982-07-26 1986-08-19 Mex Research Associates C/O Leon Reimer Monoclonal antibody to digoxin
US4510239A (en) * 1982-08-09 1985-04-09 Beckman Instruments, Inc. Double antibody immunoassays of enzymes such as prostatic acid phosphatase
GB2161165A (en) * 1984-06-12 1986-01-08 Cambridge Patent Dev Secondary antibodies
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates
DE3433652A1 (de) * 1984-09-13 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren fuer haptene und proteine

Also Published As

Publication number Publication date
ZA852438B (en) 1986-04-30
CA1277262C (en) 1990-12-04
WO1985004422A1 (en) 1985-10-10
EP0177531B1 (de) 1991-01-30
GB8408193D0 (en) 1984-05-10
AU584332B2 (en) 1989-05-25
US4840895A (en) 1989-06-20
JPS61501657A (ja) 1986-08-07
EP0177531A1 (de) 1986-04-16
JPH06102037B2 (ja) 1994-12-14
AU4154385A (en) 1985-11-01

Similar Documents

Publication Publication Date Title
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
ATE195323T1 (de) Anti-lymphotoxin-antikörper, herstellung und verwendung
DE3578418D1 (de) Chinonderivate, ihre herstellung und verwendung.
DE3682654D1 (de) Acylaminosiliciumverbindungen, deren verwendung und herstellung.
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
DE3587366D1 (de) Benzimidazol-derivate, ihre herstellung und verwendung.
DE3480794D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3480696D1 (de) Schichtstoff, seine herstellung und seine verwendung.
DE3581255D1 (de) Dns, deren herstellung und verwendung.
DE3777604D1 (de) Makrolid-verbindungen, ihre herstellung und ihre verwendung.
DE3584410D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3577719D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3784602D1 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3585095D1 (de) 6-alkyliden-peneme, ihre herstellung und verwendung sowie zwischenprodukte.
DE3682491D1 (de) Immobilisierter c-peptid-antikoerper, seine herstellung und verwendung.
DE3581981D1 (de) Polysaccharid-ron-substanz, ihre herstellung und verwendung.
DE3583296D1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
DE3789352D1 (de) Neue biphenylabkömmlinge, deren herstellung und verwendung.
DE68908389D1 (de) Amidofluoroverbindungen, ihre herstellung und ihre verwendung.
DE3577870D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3879328D1 (de) Stannosilikate, ihre herstellung und verwendung.
ATE43356T1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3578557D1 (de) Substituierte thiophen-2-sulfonamide und ihre herstellung.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: KOEPSELL, H., DIPL.-ING., PAT.-ANW., 5000 KOELN

8364 No opposition during term of opposition